Cargando…

Growth dysregulation and p53 accumulation in human primary colorectal cancer

p53 accumulation is common in colorectal cancer, but effects on growth homeostasis are unclear. In this study, DNA content, cell cycle phase fractions and DNA strand-breaks consistent with apoptosis were assessed by flow cytometry in 42 fresh primary colorectal tumours and matched normal mucosa. p53...

Descripción completa

Detalles Bibliográficos
Autores principales: Watson, D S, Brotherick, I, Shenton, B K, Wilson, R G, Campbell, F C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363047/
https://www.ncbi.nlm.nih.gov/pubmed/10362117
http://dx.doi.org/10.1038/sj.bjc.6690464
_version_ 1782153606426787840
author Watson, D S
Brotherick, I
Shenton, B K
Wilson, R G
Campbell, F C
author_facet Watson, D S
Brotherick, I
Shenton, B K
Wilson, R G
Campbell, F C
author_sort Watson, D S
collection PubMed
description p53 accumulation is common in colorectal cancer, but effects on growth homeostasis are unclear. In this study, DNA content, cell cycle phase fractions and DNA strand-breaks consistent with apoptosis were assessed by flow cytometry in 42 fresh primary colorectal tumours and matched normal mucosa. p53 accumulation was assessed in 37 fixed tumour sections, by immunohistochemistry. In normal mucosa, 10.3 ± 6.6% (mean ± s.d.) cells were in DNA synthesis phase while 28.7 ± 17.9% showed apoptosis. A relationship suggestive of growth homeostasis, was observed between these parameters (r = 0.8; P < 0.05). In cancers, a greater number of cells were in DNA synthesis phase (15.6 ± 12.9% tumour vs mucosa 10.3 ± 6.6%; P < 0.02) while fewer showed apoptosis than normal mucosa (18.5 ± 17.0% tumour vs mucosa 28.7 ± 17.9%; P < 0.01). DNA synthesis and apoptosis fractions were unrelated in cancers, suggesting growth dysequilibrium. p53 accumulation was detected in 59% (22/37) tumours and was associated with reduced apoptosis compared to p53-negative tumours or mucosa (14.8 ± 15% p53 accumulation vs 26.3 ± 18% p53-negative; P < 0.05; vs 28.7 ± 17.9% mucosa; P < 0.05). p53 accumulation was unrelated to DNA synthesis phase fractions. p53 accumulation is accompanied by reduced apoptosis which may accentuate growth dysequilibrium in colorectal cancer. © 1999 Cancer Research Campaign
format Text
id pubmed-2363047
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23630472009-09-10 Growth dysregulation and p53 accumulation in human primary colorectal cancer Watson, D S Brotherick, I Shenton, B K Wilson, R G Campbell, F C Br J Cancer Regular Article p53 accumulation is common in colorectal cancer, but effects on growth homeostasis are unclear. In this study, DNA content, cell cycle phase fractions and DNA strand-breaks consistent with apoptosis were assessed by flow cytometry in 42 fresh primary colorectal tumours and matched normal mucosa. p53 accumulation was assessed in 37 fixed tumour sections, by immunohistochemistry. In normal mucosa, 10.3 ± 6.6% (mean ± s.d.) cells were in DNA synthesis phase while 28.7 ± 17.9% showed apoptosis. A relationship suggestive of growth homeostasis, was observed between these parameters (r = 0.8; P < 0.05). In cancers, a greater number of cells were in DNA synthesis phase (15.6 ± 12.9% tumour vs mucosa 10.3 ± 6.6%; P < 0.02) while fewer showed apoptosis than normal mucosa (18.5 ± 17.0% tumour vs mucosa 28.7 ± 17.9%; P < 0.01). DNA synthesis and apoptosis fractions were unrelated in cancers, suggesting growth dysequilibrium. p53 accumulation was detected in 59% (22/37) tumours and was associated with reduced apoptosis compared to p53-negative tumours or mucosa (14.8 ± 15% p53 accumulation vs 26.3 ± 18% p53-negative; P < 0.05; vs 28.7 ± 17.9% mucosa; P < 0.05). p53 accumulation was unrelated to DNA synthesis phase fractions. p53 accumulation is accompanied by reduced apoptosis which may accentuate growth dysequilibrium in colorectal cancer. © 1999 Cancer Research Campaign Nature Publishing Group 1999-06 /pmc/articles/PMC2363047/ /pubmed/10362117 http://dx.doi.org/10.1038/sj.bjc.6690464 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Watson, D S
Brotherick, I
Shenton, B K
Wilson, R G
Campbell, F C
Growth dysregulation and p53 accumulation in human primary colorectal cancer
title Growth dysregulation and p53 accumulation in human primary colorectal cancer
title_full Growth dysregulation and p53 accumulation in human primary colorectal cancer
title_fullStr Growth dysregulation and p53 accumulation in human primary colorectal cancer
title_full_unstemmed Growth dysregulation and p53 accumulation in human primary colorectal cancer
title_short Growth dysregulation and p53 accumulation in human primary colorectal cancer
title_sort growth dysregulation and p53 accumulation in human primary colorectal cancer
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363047/
https://www.ncbi.nlm.nih.gov/pubmed/10362117
http://dx.doi.org/10.1038/sj.bjc.6690464
work_keys_str_mv AT watsonds growthdysregulationandp53accumulationinhumanprimarycolorectalcancer
AT brothericki growthdysregulationandp53accumulationinhumanprimarycolorectalcancer
AT shentonbk growthdysregulationandp53accumulationinhumanprimarycolorectalcancer
AT wilsonrg growthdysregulationandp53accumulationinhumanprimarycolorectalcancer
AT campbellfc growthdysregulationandp53accumulationinhumanprimarycolorectalcancer